Pharmaceuticals

Methenamine Hippurate Tablets Market 2025–2029: Strategic Opportunities and Growth Insights

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the methenamine hippurate tablets market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Methenamine Hippurate Tablets Market Now And By 2029?

The methenamine hippurate tablets market size has demonstrated significant expansion in recent years. This market is projected to expand from $9.52 billion in 2024 to $10.11 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be ascribed to several factors, including conventional UTI treatment practices, increasing apprehension regarding antibiotic resistance, robust clinical validation, established physician prescription patterns, and patient inclination towards non-antibiotic therapeutic options.

The methenamine hippurate tablets market is anticipated to show considerable growth in the upcoming years, expanding to $13.47 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period is due to the increasing prevalence of UTIs, rising concerns regarding antibiotic resistance, advancements in UTI management, healthcare’s emphasis on preventive therapies, and ongoing clinical trials and research. Significant trends expected during this period include a rise in UTI incidence, continued increase in antibiotic resistance, a preference for non-antibiotic treatments, a focus on preventive healthcare, and intensified research and development.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

Which Long-Term Drivers Are Expected To Sustain The Methenamine Hippurate Tablets Market?

The methenamine hippurate tablets market is anticipated to expand due to the growing geriatric population in the future. The geriatric population comprises individuals aged 60 years and above. Older patients are more susceptible to urinary tract infections, often stemming from issues like reduced urine flow, an enlarged prostate, or kidney stones, making methenamine hippurate tablets essential for managing these ailments. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations focused on international public health, predicts that by 2030, one in six people globally will be aged 60 or more. As of 2022, the number of individuals aged over 60 years stood at 1.4 billion. Globally, the population aged 60 years or more is projected to double to 2.1 billion by 2050. Furthermore, the demographic of people aged 80 years or older is expected to triple, reaching 426 million. Consequently, the expansion of the geriatric population is fueling the growth of the methenamine hippurate tablets market.

How Is The Methenamine Hippurate Tablets Market Classified By Different Segments?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

What Current And Upcoming Trends Are Shaping The Methenamine Hippurate Tablets Market?

Product innovations have emerged as the dominant trend gaining traction within the methenamine hippurate tablets market. Key companies operating in the methenamine hippurate tablets market are focused on developing new products to solidify their presence. For instance, in May 2023, EQL Pharma, a European pharmaceutical company that develops and sells cost-efficient generic and niche generic medicines to pharmacies and hospitals, announced the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in the French market. This initiative aims to broaden its availability and introduce a non-antibiotic choice for preventing UTIs. Laboratoires Majorelle, a prominent firm in women’s health in France, is set to market and distribute Memprex, thereby offering a non-antibiotic alternative for UTI prevention.

Who Are The Primary Market Leaders In The Methenamine Hippurate Tablets Market?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Methenamine Hippurate Tablets Market?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

Browse Through More Reports Similar to the Global Methenamine Hippurate Tablets Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Cough And Cold Preparations Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795